Liu P - Search Results

1

Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer.

Wu J, Shuang Z, Zhao J, Tang H, Liu P, Zhang L, Xie X, Xiao X. Wu J, et al. Among authors: liu p. Biomed Pharmacother. 2018 Jan;97:1275-1281. doi: 10.1016/j.biopha.2017.11.055. Epub 2017 Dec 14. Biomed Pharmacother. 2018. PMID: 29156515

2

Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.

Xie X, Guo J, Kong Y, Xie GX, Li L, Lv N, Xiao X, Tang J, Wang X, Liu P, Yang M, Xie Z, Wei W, Spencer DM, Xie X. Xie X, et al. Among authors: liu p. J Gene Med. 2011 Dec;13(12):680-91. doi: 10.1002/jgm.1620. J Gene Med. 2011. PMID: 22009763

3

A case report of primary small cell carcinoma of the breast and review of the literature.

Ge QD, Lv N, Cao Y, Wang X, Tang J, Xie ZM, Xiao XS, Liu P, Xie XM, Wei WD. Ge QD, et al. Among authors: liu p. Chin J Cancer. 2012 Jul;31(7):354-8. doi: 10.5732/cjc.012.10012. Epub 2012 Apr 13. Chin J Cancer. 2012. PMID: 22516480 Free PMC article. Review.

4

Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a.

Guo J, Li W, Shi H, Xie X, Li L, Tang H, Wu M, Kong Y, Yang L, Gao J, Liu P, Wei W, Xie X. Guo J, et al. Among authors: liu p. Mol Cell Biochem. 2013 Oct;382(1-2):103-11. doi: 10.1007/s11010-013-1723-6. Epub 2013 Jun 15. Mol Cell Biochem. 2013. PMID: 23771315

5

Signet-ring cell carcinoma of the breast: a case report.

Li X, Feng YF, Wei WD, Liu P, Xie ZM, Wang J, Xie XM. Li X, et al. Among authors: liu p. World J Surg Oncol. 2013 Aug 9;11(1):183. doi: 10.1186/1477-7819-11-183. World J Surg Oncol. 2013. PMID: 23938020 Free PMC article.

6

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Lin X, Wu M, Liu P, Wei F, Li L, Tang H, Xie X, Liu X, Yang L, Xie X. Lin X, et al. Among authors: liu x, liu p. Med Oncol. 2014 Apr;31(4):868. doi: 10.1007/s12032-014-0868-9. Epub 2014 Feb 22. Med Oncol. 2014. PMID: 24563327

7

Breast-conserving therapy: a viable option for young women with early breast cancer--evidence from a prospective study.

Xie Z, Wang X, Lin H, Wei W, Liu P, Xiao X, Xie X, Guan X, Yang M, Tang J. Xie Z, et al. Among authors: liu p. Ann Surg Oncol. 2014 Jul;21(7):2188-96. doi: 10.1245/s10434-014-3620-y. Epub 2014 Mar 6. Ann Surg Oncol. 2014. PMID: 24599412

8

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, Ye F, Song C, Xie X, Wei W. Chen B, et al. Among authors: liu x, liu p. Cancer Lett. 2015 Jan 28;356(2 Pt B):410-7. doi: 10.1016/j.canlet.2014.09.028. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304371

9

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Tang H, Liu P, Yang L, Xie X, Ye F, Wu M, Liu X, Chen B, Zhang L, Xie X. Tang H, et al. Among authors: liu x, liu p. Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15. Mol Cancer Ther. 2014. PMID: 25319390

10

Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a.

Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye F, Tang H, Xie X. Xiao X, et al. Among authors: liu x, liu p. PLoS One. 2014 Nov 14;9(11):e112720. doi: 10.1371/journal.pone.0112720. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2023 Dec 12;18(12):e0295991. doi: 10.1371/journal.pone.0295991 PMID: 25396727 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,113 results

Search Page

Filters